関連する実験動画
Updated: Sep 8, 2025

14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
32.0K
小児性喘息患者に対するEMS投与によるコスト削減
Jennifer Fishe1,2, Gerard Garvan2, Lauren Riney3
1Department of Emergency Medicine, College of Medicine, University of Florida, Jacksonville, FL, United States.
Frontiers in public health
|September 3, 2025
まとめ
小児性喘息の患者に支障管拡張剤とコルチコステロイドを投与する緊急医療サービス (EMS) は,入院と医療費を大幅に削減することができます. EMSによる早期治療は,特に軽度な症例と長い輸送時間の場合,コストを削減します.
科学分野:
- 小児の緊急医療
- 健康 経済
- 呼吸器医学
背景:
- 小児性喘息の悪化は,主に入院による,米国におけるかなりの医療費につながります.
- 緊急医療サービス (EMS) の介入は,緊急治療室 (ED) の到着前に費用対効果が評価されています.
- この研究は,小児性喘息の病院前治療の経済的影響に焦点を当てています.
研究 の 目的:
- 小児性喘息患者に対する EMS投与によるコスト削減を分析する.
- EMSで治療された小児喘息患者の入院率と,ED到着後に治療された患者の入院率を比較する.
- 小児性喘息の悪化に対する早期の薬理学的介入の経済的利益を決定する.
主な方法:
- 小児性喘息のプロトコルを確立した7つのEMS機関からのデータの経済分析.
- 1回の入院を防ぐために必要な治療数 (NNT) の計算
- NNTと小児性喘息の入院費用に基づくコスト削減の見積もり
主要な成果:
- 全国で EMSによるこれらの薬の投与により 1,913件の入院が回避され,6,886,800ドルの節約ができました.
- 軽度の悪化の場合,NNTは9で,長時間輸送の場合 (> 40分) は6でした.
- 軽度の症例と長期間の輸送をターゲットにすることで,6,833件の軽度の悪化と500件の長期間の輸送入院を防ぐことができ, 26,398,800ドルの節約が可能になります.
結論:
- 呼吸器拡張剤と全身用コルチコステロイドのEMS投与は,小児性喘息の費用対効果の高い戦略です.
- 特に軽度の喘息の患者や,EMSの輸送時間が長い小児患者の場合,かなりのコスト削減が可能である.
- EMSによる早期介入は,小児性喘息の入院と関連する医療費を減らすことができます.
関連する概念動画
COPD: Management Using Bronchodilators and Corticosteroids
300
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
300
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
382
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
382
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Antiasthma Drugs: β2-Adrenoceptor Agonists
374
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
374
Inhaled Medications
387
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
387
Drugs Used in Lower Respiratory Disorders: Overview
573
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
573

